Genetic risk factor of COPD
Even if an individual has never smoked or been unprotected to pollutants for an extended period of time, they can still develop COPD. Alpha-1 Antitrypsin Deficiency (AATD) is the most commonly known genetic risk factor of COPD in emphysema. Alpha-1 Antitrypsin related COPD is caused by a deficiency of the Alpha-1 in the bloodstream. Without the Alpha-1 Antitrypsin protein, white blood cells begin to harm the lungs and lung deterioration occurs. The World Health Organization and the American Thoracic Society suggests that each individual determined to have COPD be tested for Alpha-1. Pulmonary Conferences also discusses about different types of genes which may be a cause of pulmonary diseases.
Related Conference of Genetic risk factor of COPD
17th International Conference on Chronic Obstructive Pulmonary Disease
14th International Conference on COPD Clinical Trials & Lung Care Advances
16th International Conference on Pulmonary & Respiratory Medicine
Genetic risk factor of COPD Conference Speakers
Recommended Sessions
- Asthma and COPD
- Chronic Obstructive Pulmonary Disease
- Co-Morbidities of COPD
- COPD and Cardiovascular Diseases
- COPD Complications
- COPD Exacerbations
- COPD Pathogenesis
- COPD Therapeutics
- COPD: Sign and Symptoms
- Depression and anxiety in COPD
- Drug Discovery of COPD
- Epidemiology of COPD
- Genetic risk factor of COPD
- Lung cancer
- Pathophysiology of COPD
- Pediatric Pulmonary, Critical care and Sleep
- Pulmonary diseases-treatment and therapies
- Pulmonary Hypertension
- Self-Management and Prevention of COPD
- Types of COPD
Related Journals
Are you interested in
- Advances in Mechanical Ventilation and Respiratory Support - Pulmonology-2026 (Spain)
- Airway Management Techniques in Critical Care Settings - Pulmonology-2026 (Spain)
- Asthma and COPD - COPD_2025 (Spain)
- Asthma Management: Guidelines and Personalized Therapy - Pulmonology-2026 (Spain)
- Chronic Obstructive Pulmonary Disease - COPD_2025 (Spain)
- Chronic Obstructive Pulmonary Disease (COPD) Updates - Pulmonology-2026 (Spain)
- Co-Morbidities of COPD - COPD_2025 (Spain)
- COPD and Cardiovascular Diseases - COPD_2025 (Spain)
- COPD Complications - COPD_2025 (Spain)
- COPD Exacerbations - COPD_2025 (Spain)
- COPD Pathogenesis - COPD_2025 (Spain)
- COPD Therapeutics - COPD_2025 (Spain)
- COPD: Sign and Symptoms - COPD_2025 (Spain)
- Critical Care Strategies in Sepsis and Multi-Organ Failure - Pulmonology-2026 (Spain)
- Depression and anxiety in COPD - COPD_2025 (Spain)
- Drug Discovery of COPD - COPD_2025 (Spain)
- Epidemiology of COPD - COPD_2025 (Spain)
- Ethical Dilemmas and Decision-Making in ICU Settings - Pulmonology-2026 (Spain)
- Genetic risk factor of COPD - COPD_2025 (Spain)
- Immunotherapy and Biologics in Respiratory Diseases - Pulmonology-2026 (Spain)
- Innovations in Interventional Pulmonology - Pulmonology-2026 (Spain)
- Lung cancer - COPD_2025 (Spain)
- Lung Cancer Screening, Diagnosis, and Interventions - Pulmonology-2026 (Spain)
- Lung Infections: Tuberculosis, Pneumonia, and Beyond - Pulmonology-2026 (Spain)
- Management of Acute Respiratory Distress Syndrome (ARDS) - Pulmonology-2026 (Spain)
- Non-Invasive Ventilation in Acute and Chronic Care - Pulmonology-2026 (Spain)
- Pathophysiology of COPD - COPD_2025 (Spain)
- Pediatric Pulmonary, Critical care and Sleep - COPD_2025 (Spain)
- Pediatric Pulmonology and Critical Care Challenges - Pulmonology-2026 (Spain)
- Point-of-Care Ultrasound in Critical Care Medicine - Pulmonology-2026 (Spain)
- Post-COVID Pulmonary Complications and Long-Term Care - Pulmonology-2026 (Spain)
- Pulmonary diseases-treatment and therapies - COPD_2025 (Spain)
- Pulmonary Fibrosis and Interstitial Lung Disease - Pulmonology-2026 (Spain)
- Pulmonary Hypertension - COPD_2025 (Spain)
- Pulmonary Hypertension: Diagnosis and Emerging Therapies - Pulmonology-2026 (Spain)
- Pulmonary Rehabilitation and Patient-Centered Recovery - Pulmonology-2026 (Spain)
- Role of Imaging in Pulmonary Diagnostics and ICU Care - Pulmonology-2026 (Spain)
- Self-Management and Prevention of COPD - COPD_2025 (Spain)
- Sleep-Disordered Breathing and CPAP Therapies - Pulmonology-2026 (Spain)
- Types of COPD - COPD_2025 (Spain)

